We are Sorry, This Page doesn't Exist
Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment
Vertex Pharmaceuticals shares saw a handy gain on Thursday after the FDA gave a nod to Vertex’s cystic fibrosis treatment......»»
A Biotech Giant Not Named Biogen Also Had a Good Week
A rapid-fire cystic-fibrosis drug approval and crucial U.K. deal deliver a double dose of good news for Vertex Pharmaceuticals......»»
Vertex announces FDA approval of ORKAMBI to treat cystic fibrosis
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex"s Cystic Fibrosis Drug Gets FDA Nod for Children
Vertex's (VRTX) cystic fibrosis drug, Kalydeco gets FDA approval to treat children aged 12 months to two years .....»»
Vertex"s Orkambi Wins EU Nod to Treat Cystic Fibrosis in Kids
Vertex (VRTX) gains an EU approval for Orkamb.....»»
Vertex Pharmaceutical"s Move Beyond Its $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune
Vertex Pharma.....»»
Eloxx adds additional treatment arm to ongoing Phase 2 Cystic Fibrosis studies
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex sets higher 2020 revenue target due to ‘remarkable’ CF drug sales
While other companies are tempering or staying mum on annual sales forecasts amid the COVID-19 pandemic, booming sales of its new cystic fibrosis drug have led Vertex to increase its expectations......»»
Vertex"s cystic fibrosis medicines accepted by NHS Wales
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex confirms Northern Ireland offer accepted for cystic fibrosis medicines
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex raises 2019 cystic cystic fibrosis sales outlook to $3.7B-$3.75B
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA approves Vertex Pharmaceuticals" Trikafta for cystic fibrosis
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA expands approval of Symdeko for cystic fibrosis to patients ages 6 and older
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex"s Latest Data May Lead To Expanded Cystic Fibrosis Market
Vertex"s Latest Data May Lead To Expanded Cystic Fibrosis Market.....»»
Armata jumps after journal publishes treatment of cystic fibrosis patient
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Atlas-backed Kymera signs deal with Vertex worth up to $1B
Cambridge startup Kymera Therapeutics just earned $70 million and could get up to $1 billion after signing a four-year collaboration deal with Vertex Pharmaceuticals. Vertex (Nasdaq: VRTX) has cornered the market for cystic fibrosis, a rare geneti.....»»
Proteostasis Plunges on Weak Data From Cystic Fibrosis Study
Proteostasis (PTI) announces data from a phase I study evaluating its triplet combination in cystic fibrosis. Although data were promising, it was weaker than rival Vertex's triplet combinations. Want the.....»»
Vertex Hits Stumbling Block For One Triple-Combo Therapy For Cystic Fibrosis
Vertex Hits Stumbling Block For One Triple-Combo Therapy For Cystic Fibrosis.....»»
Arrowhead presents new data on ARO-ENac for treatment of Cystic Fibrosis
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Vertex Hits The Top, As Competitor Galapagos Doesn"t Impress In Cystic Fibrosis Study
Vertex Hits The Top, As Competitor Galapagos Doesn"t Impress In Cystic Fibrosis Study.....»»